Enkephalin Release Rat brain experiments reported changes in the release of immunoreactive met-enkephalin following DSIP exposure
While GLP-1 receptor agonists offer advantages for weight loss and diabetes control, they also pose significant risks, including thyroid C-cell tumors, acute pancreatitis, and kidney injury
Contact your GP for routine assessment if: Urinary frequency significantly disrupts daily activities or sleep You notice persistent changes in urine colour, smell, or appearance Urinary symptoms persist beyond the initial adjustment period (typically 48 weeks) You have concerns about medication side effects or diabetes control Your healthcare provider can perform appropriate investigations, including urinalysis, renal function tests, and HbA1c measurement, to determine the underlying cause of urinary changes and adjust your treatment plan accordingly
Grey-market vendors often manufacture or repackage multiple compounds in the same facility, sometimes using the same equipment